Advertisement
Screener

Bausch & Lomb Corp (BLCO) Overview

Bausch & Lomb Corp (BLCO) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.04; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.20; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.08; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.18; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$13.83$15.03$16.34$17.76$19.30$20.982025-11-062026-11-06$10.35$12.04$14.01$16.29$18.95$22.042022-05-062026-11-06$10.35$12.04$14.01$16.29$18.95$22.042022-05-062026-11-06$10.35$12.04$14.01$16.29$18.95$22.042022-05-062026-11-06$10.35$12.04$14.01$16.29$18.95$22.042022-05-062026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$19.98
Previous close
$17.14
Change
$2.84
Change (%)
16.57%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

BLCO
+0.35%
S&P 500
(m)

1 year

BLCO
+14.57%
S&P 500
(m)

3 years

BLCO
+1.12%
S&P 500
(m)

5 years

BLCO
(m)
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.04

-0.68-0.47-0.27-0.060.1431 Mar 2025: estimate (m); actual -0.6031 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.1830 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.0830 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.2031 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.0430 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.04(m)(m)
1 Jan 202631 Mar 2026(m)-0.20(m)(m)
1 Jul 202530 Sept 2025(m)-0.08(m)(m)
1 Apr 202530 Jun 2025(m)-0.18(m)(m)
1 Jan 202531 Mar 2025(m)-0.60(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -1.02

-1.10-0.65-0.200.250.7031 Dec 2021: estimate (m); actual 0.5231 Dec 2021(m)31 Dec 2022: estimate (m); actual 0.0231 Dec 2022(m)31 Dec 2023: estimate (m); actual -0.7431 Dec 2023(m)31 Dec 2024: estimate (m); actual -0.9031 Dec 2024(m)31 Dec 2025: estimate (m); actual -1.0231 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-1.02(m)(m)
1 Jan 202431 Dec 2024(m)-0.90(m)(m)
1 Jan 202331 Dec 2023(m)-0.74(m)(m)
1 Jan 202231 Dec 2022(m)0.02(m)(m)
1 Jan 202131 Dec 2021(m)0.52(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 1.39B ■ Earnings -0.01B — Profit margin -1.00%

-0.25B-6.7%0.36B-4.5%0.97B-2.2%1.58B-0.0%30 Sept 2025: revenue 1.28B; earnings -0.03B; profit margin -2.19%30 Sept 202531 Dec 2025: revenue 1.41B*; earnings -0.06B*; profit margin -4.13%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 1.24B; earnings -0.07B; profit margin -5.71%31 Mar 202630 Jun 2026: revenue 1.39B; earnings -0.01B; profit margin -1.00%30 Jun 2026

31 Dec 2025 ■ Revenue 5.10B ■ Earnings -0.36B — Profit margin -7.06%

-1.02B-8.1%1.24B-5.0%3.50B-1.9%5.76B1.2%31 Dec 2022: revenue 3.77B; earnings 0.01B; profit margin 0.16%31 Dec 202231 Dec 2023: revenue 4.15B; earnings -0.26B; profit margin -6.27%31 Dec 202331 Dec 2024: revenue 4.79B; earnings -0.32B; profit margin -6.62%31 Dec 202431 Dec 2025: revenue 5.10B; earnings -0.36B; profit margin -7.06%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$19.98(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$19.98High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning BLCO

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-13; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-171.00M
Profit margin
-3.21%
Return on assets · 12 month
-1.24%
Index membership
(m)
Employees
13.00K
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
358.03K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-1.04%*
Total return · month
-0.06%*
Total return · quarter
3.07%*
Total return · half year
11.52%*
Total return · year to date
0.35%*
Total return · 1 year
14.57%*
Total return · 3 years
1.12%*
Total return · 5 years
(m)
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$5.32B
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
79.63%*
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

Bausch & Lomb Corp Overview

View more →

(m)

(m)

SEC CIK
1860742
Industry (SIC)
3851 Ophthalmic Goods
Country of operation
(m)
Business address
520 APPLEWOOD CRESCENT, VAUGHAN, L4K 4B4
Fiscal year end
1231
Phone
908-541-5456

Similar stocks

Stock NameCountryMarket CapPE Ratio
Warby Parker Inc. (WRBY)United States$2.970B
COOPER COMPANIES, INC. (COO)United States$10.533B24.09
National Vision Holdings, Inc. (EYE)United States$1.297B
STAAR SURGICAL CO (STAA)United States$0.957B362.70
RxSight, Inc. (RXST)United States$0.197B
Innovative Eyewear Inc (LUCY)United States$0.008B